Dr. Thomas Kingsley Brown has been researching, writing about, and speaking about ibogaine treatment for substance dependence since 2009, when he interviewed patients at a treatment center in Baja California, Mexico to learn about their experiences. With funding from MAPS (the Multidisciplinary Association for Psychedelic Studies) he then conducted a Mexico-based study of outcomes for people receiving ibogaine-assisted treatment for opioid dependence. He has published a review article on ibogaine treatment (Current Drug Abuse Reviews, 2013), an article on the results of the research study (T.K. Brown and K. Alper, American Journal of Drug and Alcohol Abuse, 2017) and an article on the therapeutic role of the altered states elicited by ibogaine (T.K. Brown, G.E. Noller, and J.O. Denenberg, J. Psychedelic Studies, 2019). He has been an invited speaker at several conferences, including the National Harm Reduction Conference (USA), Horizons: Perspectives on Psychedelics (New York City), the European Ibogaine Conference (Wien), TEDx Venice Beach, the annual conference of the American Association of Addiction Psychiatry, and the 2018 Colloquium on Psychedelic Psychiatry (Stockholm). Dr. Brown's academic training is in chemistry (B.S., University of Pittsburgh; M.S., California Institute of Technology) and anthropology (Ph.D., UC San Diego).